Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 181

The DOI matches its Crossref record.

Association between anti–cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis

López‐Longo, Francisco Javier, Oliver‐Miñarro, Desamparados, de la Torre, Inmaculada, González‐Díaz de Rábago, Eugenia, Sánchez‐Ramón, Silvia, Rodríguez‐Mahou, Margarita, Paravisini, Alexandra, Monteagudo, Indalecio, González, Carlos‐Manuel, GarCía‐Castro, Marta, Casas, María Dolores, Carreño, Luis · 2009 · Arthritis Care & Research

Abstract

Objective: Patients with rheumatoid arthritis (RA) have an increased risk of cardiovascular disease that may not always be related to the presence of traditional cardiovascular risk factors. The aim of this study was to determine if anti–cyclic citrullinated peptide (anti‐CCP) antibodies are associated with cardiovascular disease in patients with RA. Methods: Anti‐CCP antibodies were determined by enzyme‐linked immunosorbent assay in the earliest serum sample available from 937 patients with a diagnosis of RA. We studied the relationship between anti‐CCP antibodies with traditional cardiovascular risk factors and cardiovascular events. Results: We found positive anti‐CCP antibodies (>25 units/ml) in 672 patients (71.7%). There was no association between the anti‐CCP antibodies and cardiovascular risk factors such as smoking, hypertension, dyslipidemia, being overweight, or diabetes mellitus. However, patients who had positive anti‐CCP antibodies experienced more frequent ischemic heart disease (6.5% versus 2.6%; odds ratio [OR] 2.58, 95% confidence interval [95% CI] 1.17–5.65) and had higher mortality rates (11.2% versus 6.8%; OR 1.72, 95% CI 1.01–2.91). Similar results were obtained when we considered anti‐CCP titers 20‐fold higher (>500 units/ml). Multivariable analysis showed that ischemic heart disease is independently associated with positive anti‐CCP antibodies (OR 2.8, 95% CI 1.19–6.56; P = 0.009). Conclusion: Anti‐CCP antibodies in patients with RA are independently associated with the development of ischemic heart disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.24390

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 181

Metadata

Authors
López‐Longo, F. J., Oliver‐Miñarro, D., de la Torre, I., González‐Díaz de Rábago, E., Sánchez‐Ramón, S., Rodríguez‐Mahou, M., Paravisini, A., Monteagudo, I., González, C., GarCía‐Castro, M., Casas, M. D., & Carreño, L.
Venue
Arthritis Care & Research
Publisher
Wiley
Published
2009-03-30
Volume
61
Issue
4
Pages
419-424
ISSN
  • 0893-7524 (ISSN-L)
  • 1529-0123
OpenAlex
W1996168629
Cited by
181
References
0
FWCI
7.40
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Association between anti–cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis. https://app.cochat.ai/papers/10.1002/art.24390
The paper
López‐Longo, F. J., Oliver‐Miñarro, D., de la Torre, I., González‐Díaz de Rábago, E., Sánchez‐Ramón, S., Rodríguez‐Mahou, M., Paravisini, A., Monteagudo, I., González, C., GarCía‐Castro, M., Casas, M. D., & Carreño, L. (2009). Association between anti–cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis. Arthritis Care & Research. https://doi.org/10.1002/art.24390

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.